Search
Standard BioTools Inc
LABAdd to Watchlist
0.989USD
+0.004+0.44%
Close 05/18, 16:00（ET）Quotes delayed by 15 min
385.89MMarket Cap
4.95P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.44%
5 Days
-0.09%
1 Month
+6.37%
6 Months
-20.23%
Year to Date
-22.73%
1 Year
-8.42%
TradingKey Stock Score of Standard BioTools Inc
Currency: USD Updated: 2026-05-15Key Insights
Standard BioTools Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 90 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 1.55.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Standard BioTools Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Standard BioTools Inc Highlights
StrengthsRisks
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Growing
The company is in a growing phase, with the latest annual income totaling USD 85.33M.
Overvalued
The company’s latest PE is 4.93, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 317.36M shares, increasing 0.24% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 32.62K shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
1.550
Target Price
+57.39%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Standard BioTools Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Standard BioTools Inc Info
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Ticker SymbolLAB
CompanyStandard BioTools Inc
CEOEgholm (Michael)
Websitehttps://www.standardbio.com/
Related Instruments
-0.69%
+0.83%
+4.46%
+4.07%
+0.10%
+2.11%
+1.20%
+1.54%
-0.05%
+0.35%
+6.15%
+0.50%
+1.61%
+1.24%
+3.21%
-0.78%
+0.29%
+3.66%
+0.37%
-0.47%Popular Instruments
102.273
-0.183 (-0.18%)
297.840
-2.390 (-0.80%)
222.320
-3.000 (-1.33%)
4575.380
+9.260 (+0.20%)
458.680
-23.340 (-4.84%)
1333.010
-74.600 (-5.30%)
681.540
-43.120 (-5.95%)
396.940
+0.160 (+0.04%)
77193.540
+313.620 (+0.41%)
409.990
-12.250 (-2.90%)
